Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
Institute of Oncology Ljubljana
The Institute of Molecular and Translational Medicine, Czech Republic
Dana-Farber Cancer Institute
National University Hospital, Singapore
Boston Children's Hospital
Jewish General Hospital
M.D. Anderson Cancer Center
City of Hope Medical Center
Erasmus Medical Center
SOLTI Breast Cancer Research Group
University Hospital, Montpellier
University Hospital, Montpellier
Gustave Roussy, Cancer Campus, Grand Paris
SOLTI Breast Cancer Research Group
Helse Nord-Trøndelag HF
University of Wisconsin, Madison
University Hospital, Ghent
Fundacion Clinic per a la Recerca Biomédica
Fundacion Clinic per a la Recerca Biomédica
University Health Network, Toronto
Australian & New Zealand Children's Haematology/Oncology Group
Oncology Institute of Southern Switzerland
Peking University People's Hospital